- EXCLUSIVE: Aesther Healthcare's Merger Partner Ocean Biomedical Unveils Discovery Data For Major Anti-Tumor Pathway In Skin Cancer
- EXCLUSIVE: Aesther Acquisition Corp. Merger Partner, Ocean Biomedical Tells Benzinga Co Announces Publication Of Discovery Data For A Major Anti-Tumor Pathway In Malignant Melanoma And Other Cancers
- Exclusive: The Parent Company Announces Social Equity Program For Minority-Owned Brands
- EXCLUSIVE: AgriFORCE Agrees To Snap Berry People For $28M And Earnout Provision To Tap Budding Berries Market
- EXCLUSIVE: AgriForce Says 'Acquisition of berry business brings an established distribution network and clients including over 200 retail and foodservice companies and over 100 growers and exporters across the US, Canada, Mexico, and Peru'
- EXCLUSIVE: AgriFORCE Tells Benzinga 'Berry People's 2022 unaudited net revenue was USD $37 million'
- EXCLUSIVE: AgriFORCE Growing Systems Tells Benzinga Co. Has Entered Binding LOI To Acquire 70% Of Berry People LLC's Equity Interest For $18.2M In Cash And $9.8M In AgriFORCE Restricted Shares
- No Wheelchair Fit This Founder's Needs so He Built His Own and Now It's Backed by TechStars and an XTC Global Finalist
- EXCLUSIVE: Illegal Short-Selling Scheme Puts Genius Group In David Vs. Goliath Fight
- EXCLUSIVE: SAB Biotherapeutics Tells Benzinga Co. Has Received An Additional $8.2M From DoD Related To Closeout Of The Discontinued COVID-19 Prototype Research And Development Contract
- EXCLUSIVE: SAB Biotherapeutics' Type 1 Diabetes Candidate Moves One Step Closer To Enter Human Trials With Completion Of Toxicology Study
- EXCLUSIVE: SAB Biotherapeutics Tells Benzinga Co. Has Successfully Concluded IND-Enabling GLP Toxicology Study For SAB-142, A Novel Immunotherapeutic For Type 1 Diabetes; Co. To Submit IND Filing Within Approximately 12 Months
Benzinga EventsSee more
- Cannabis Capital ConferenceApril 11-12, 2023 | Fontainebleau Miami Beach, Florida
- Psychedelics Capital ConferenceApril 13, 2023 | Fontainebleau Miami Beach, Florida
- Cannabis Conference & AwardsFall 2023
- Future of Crypto by BenzingaWinter 2023
- Fintech Deal Day & AwardsWinter 2023
- All Access: StocksVirtual
Compare Benzinga's Favorite Stock Brokers
Compare Benzinga's Favorite Cryptocurrency Brokers
This ad promotes virtual cryptocurrency investing within the EU (by eToro Europe Ltd. and eToro UK Ltd.) and USA (by eToro USA LLC); which is highly volatile, unregulated in most EU countries, no EU protections and not supervised by the EU regulatory framework. Investments are subject to market risk, including the loss of principal.